Brief: Monopar Therapeutics Announces Pricing Of $135 Million Underwritten Offering Of Common Stock And Pre-Funded Warrants
24/09/2025 04:09
Sept 23 (Reuters) - Monopar Therapeutics Inc MNPR.O: MONOPAR THERAPEUTICS INC. ANNOUNCES PRICING OF $135 MILLION UNDERWRITTEN OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS MONOPAR THERAPEUTICS INC - PRICES 1,034,433 SHARES AT $67.67 PER SHARE Source text: ID:nGNX3vP088 Further company coverage: MNPR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Monopar Therapeutics
See all newsBrief: Monopar Appoints Jeffrey D. Kent, M.D., As Executive Vice President, Head Of Medical Affairs Announces Two Alxn1840 Presentations At Aasld – The Liver Meeting 2026
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Monopar Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Monopar Therapeutics Inc. expected to post a loss of 62 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Alphabet, IBM, Tesla